Federation des caisses Desjardins du Quebec’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.7M Sell
59,145
-76,604
-56% -$36.8M 0.09% 165
2026
Q1
$66.7M Sell
135,749
-12,740
-9% -$6.91M 0.24% 68
2025
Q4
$86M Buy
148,489
+5,839
+4% +$3.3M 0.33% 58
2025
Q3
$69.2M Buy
142,650
+57,166
+67% +$26.6M 0.27% 61
2025
Q2
$34.7M Buy
85,484
+9,483
+12% +$3.96M 0.15% 118
2025
Q1
$37.8M Buy
76,001
+3,415
+5% +$1.85M 0.19% 101
2024
Q4
$37.7M Buy
72,586
+5,860
+9% +$3.22M 0.19% 95
2024
Q3
$41.3M Sell
66,726
-4,461
-6% -$2.64M 0.2% 88
2024
Q2
$39.4M Sell
71,187
-9,413
-12% -$5.39M 0.21% 83
2024
Q1
$44.7M Buy
80,600
+5,900
+8% +$3.31M 0.32% 63
2023
Q4
$39.7M Sell
74,700
-13,783
-16% -$6.67M 0.37% 57
2023
Q3
$44.8M Buy
88,483
+2,588
+3% +$1.38M 0.46% 51
2023
Q2
$44.8M Buy
85,895
+11,428
+15% +$6.17M 0.44% 51
2023
Q1
$42.9M Sell
74,467
-2,267
-3% -$1.28M 0.47% 49
2022
Q4
$42.3M Buy
76,734
+720
+0.9% +$382K 0.5% 46
2022
Q3
$38.6M Buy
76,014
+742
+1% +$415K 0.46% 53
2022
Q2
$40.9M Buy
75,272
+946
+1% +$521K 0.46% 52
2022
Q1
$43.9M Buy
74,326
+6,163
+9% +$3.54M 0.42% 52
2021
Q4
$45.5M Buy
68,163
+7,108
+12% +$4.44M 0.45% 52
2021
Q3
$34.9M Sell
61,055
-24,486
-29% -$13.4M 0.36% 58
2021
Q2
$43.1M Buy
85,541
+23,737
+38% +$11.2M 0.44% 53
2021
Q1
$28.2M Buy
61,804
+25,897
+72% +$12.4M 0.31% 66
2020
Q4
$16.7M Buy
35,907
+6,577
+22% +$3.08M 0.2% 103
2020
Q3
$13M Buy
29,330
+3,604
+14% +$1.49M 0.18% 113
2020
Q2
$9.35M Sell
25,726
-2,075
-7% -$696K 0.14% 141
2020
Q1
$7.98M Sell
27,801
-4,722
-15% -$1.49M 0.14% 129
2019
Q4
$10.6M Buy
32,523
+724
+2% +$220K 0.15% 121
2019
Q3
$9.27M Buy
31,799
+3
+0% +$859 0.13% 129
2019
Q2
$9.32M Buy
31,796
+123
+0.4% +$33.9K 0.14% 132
2019
Q1
$8.67M Sell
31,673
-373
-1% -$92.8K 0.13% 144
2018
Q4
$7.18M Sell
32,046
-1,287
-4% -$302K 0.12% 157
2018
Q3
$8.14M Sell
33,333
-2,510
-7% -$577K 0.12% 161
2018
Q2
$7.43M Sell
35,843
-3,269
-8% -$694K 0.11% 163
2018
Q1
$8.08M Sell
39,112
-917
-2% -$192K 0.13% 154
2017
Q4
$7.59M Buy
40,029
+27,324
+215% +$5.23M 0.11% 171
2017
Q3
$2.4M Buy
12,705
+34
+0.3% +$6.16K 0.04% 388
2017
Q2
$2.21M Buy
12,671
+21
+0.2% +$3.53K 0.04% 402
2017
Q1
$1.94M Buy
+12,650
New +$1.93M 0.04% 393

Other funds holding TMO

Federation des caisses Desjardins du Quebec's TMO Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec reduced its Thermo Fisher Scientific (TMO) stake by 56% in Q2 2026, selling an estimated $36.8M and leaving 59,145 shares worth $29.7M. The position accounts for 0.09% of the portfolio, ranked #165.

Federation des caisses Desjardins du Quebec first reported a position in TMO in Q1 2017 and has held it in 38 quarters since. The position peaked at $86M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 59,145 shares of Thermo Fisher Scientific worth $29.7M as of Q2 2026.
  • Federation des caisses Desjardins du Quebec sold 76,604 Thermo Fisher Scientific shares in Q2 2026, an estimated $36.8M.
  • Thermo Fisher Scientific made up 0.09% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #165 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 38 quarters since.
  • Federation des caisses Desjardins du Quebec's Thermo Fisher Scientific position peaked at $86M in Q4 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.